Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept IV in Japanese Pediatric JIA
NCT01835470Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2013
- Primary completion
- Nov 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in juvenile idiopathic arthritis (JIA), sponsored by Bristol Myers Squibb. Started Aug 2013; status: completed.
02
Drugs
abatacept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT01835470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01835470.